Drug recall · October 22, 2025
Everolimus tablets 5mg recall
Why: Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91
- Lots / codes
Lot #: 550172301, Exp. Date January 2026
- Quantity
- 1,041 cartons
- Company
- Endo USA, Inc., Malvern, PA
- Distribution
- Nationwide within the United States
- Initiated
- September 5, 2025 · Voluntary: Firm initiated
- Classified
- October 16, 2025
- Reported
- October 22, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Everolimus
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.